The SP is a joke so might aswell get a laugh out of it.
We aren't down here only because of downramping on HC. Buyers aren't lining up like you would expect from either the Acromegaly trial results or the statements about pharma due diligence. Maybe past history of p&d has something to do with it? Maybe people just don't believe the Diamond like Itsa does.
Its a kick in the guts but the thing that keeps me hanging in are the trial results. I can't see a fault in them, they look like the drug will be a knockout. The frustrating thing is it won't be conclusive until the higher dose trial is done. But I think the results that we already have should be enough to get a pharma to bite as the Diamond is suggesting.
ANP Price at posting:
9.7¢ Sentiment: Buy Disclosure: Held
